2023年ACR/EULAR对抗脂综合征的分类标准的影响以及当前的诊断和治疗见解:德尔菲共识共识
Drs B C Geertsema-Hoeve1, Dr M C Stam-Slob2, Dr M Bijl3
1Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, the Netherlands.
The American journal of medicine
|February 15, 2026
概括
新的抗脂综合征 (APS) 分类标准有助于研究,但不是用于临床诊断. 专家强调认识到微血管APS,以获得更好的患者结果和更早的诊断.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 为研究而引入了2023年ACR/EULAR对抗脂综合征 (APS) 的分类标准.
- 临床实践需要对APS诊断和治疗的最新见解.
研究的目的:
- 检查新APS分类标准的影响.
- 在临床实践中为APS提供最新的诊断和治疗见解.
主要方法:
- 一个德尔菲共识方法,涉及19名荷兰专家.
- 两轮调查和最后一次讨论,以达成对25个声明的共识.
主要成果:
- 92%的陈述达到了共识.
- 新的标准增强了研究风险分层,但不是用于临床诊断.
- 产科APS患者可能不符合新的研究标准;注意微血管疾病的重点.
结论:
- 新的APS标准对研究有价值,但需要在临床环境中仔细应用.
- 识别微血管APS表现对于及时诊断和改善结果至关重要.
- 实验室标准化和对替代抗凝剂的谨慎考虑是重要的临床挑战.
相关概念视频
Atherosclerosis III: Management
459
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459
Peripheral Artery Disease III: Interprofessional Care
374
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
374
Acute Coronary Syndrome III: Diagnostic Studies
294
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
294
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
462
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
462
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
586
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
586
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.3K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.3K
